SCHEMBL28992126

SCHEMBL28992126

CC(C)(C)OC(=O)NC/C(=C\F)COc1ccc2ncccc2c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ KDM4E B2RXH2 5/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ P2RY14 Q15391 2/20 0.37
▸ NOTUM Q6P988 1/20 0.37
▸ PLK1 P53350 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228559 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EL3MBTL1HTTMAPK1
SCHEMBL28992114 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EL3MBTL1HTTMAPK1
SCHEMBL30228856 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EL3MBTL1HTTMAPK1
SCHEMBL30228528 0.89 RAB9A (0.41) ALDH1A1KDM4EHTTRAB9ANPC1
SCHEMBL30228810 0.86 MIF (0.41) ALDH1A1KDM4ERAB9ANPC1MAPT
SCHEMBL21864827 0.85 KDM4E (0.37) KDM4ERAB9ANPC1MAPT
SCHEMBL21864837 0.84 KDM4E (0.42) ALDH1A1KDM4ERAB9ANPC1MAPT
SCHEMBL28992119 0.84 MIF (0.42) KDM4ERAB9ANPC1MAPT
SCHEMBL21865489 0.83 KDM4E (0.43) ALDH1A1KDM4ERAB9ANPC1MAPT
SCHEMBL21864962 0.83 KDM4E (0.41) ALDH1A1KDM4ERAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109988106-B Amine compound for inhibiting SSAO/VAP-1 and application thereof in medicine 广东东阳光药业有限公司 2023-03-31 — — CN disclosed
Send feedback